Join to View Full Profile
603 N Flamingo RdSte 151Pembroke Pines, FL 33028
Phone+1 954-265-4325
Fax+1 954-436-4606
Dr. Deutsch is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Miami/Jackson Health SystemFellowship, Hematology and Medical Oncology, 2012 - 2015- University of Miami/Jackson Health SystemResidency, Internal Medicine, 2009 - 2012
University of Miami Leonard M. Miller School of MedicineClass of 2009
Certifications & Licensure
FL State Medical License 2015 - 2027
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 9 citationsMutations highly specific for secondary AML are associated with poor outcomes in ELN favorable risk NPM1-mutated AML.Onyee Chan, Najla Al Ali, Hammad Tashkandi, Austin Ellis, Somedeb Ball
Blood Advances. 2024-03-12 - 13 citationsMolecular annotation of extramedullary acute myeloid leukemia identifies high prevalence of targetable mutations.Somedeb Ball, Todd C Knepper, Yehuda E Deutsch, Wassim Samra, Justin M Watts
Cancer. 2022-11-01 - 8 citationsCPX-351 Yields Similar Response and Survival Outcome in Younger and Older Patients With Secondary Acute Myeloid Leukemia.Dasom Lee, Akriti G Jain, Yehuda Deutsch, Jennifer Eatrides, Onyee Chan
Clinical Lymphoma, Myeloma & Leukemia. 2022-10-01
Abstracts/Posters
- Hypomethylating Agent and Venetoclax Combination Therapy Yields Superior Outcomes When Compared to Hypomethylating Agent Monotherapy in Patients _70 Years with Acute M...Yehuda E. Deutsch, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- CPX-351 As Induction Chemotherapy Yields Similar Responses and Survival Outcomes in Younger Patients (<60 Years Old) Compared to Older Patients (_60 Years Old) with Ac...Yehuda E. Deutsch, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Outcomes of Patients with Relapsed or Refractory Acute Myeloid Leukemia Receiving Hypomethylating Agent and VenetoclaxYehuda E. Deutsch, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Lectures
- Safety and Efficacy of Midostaurin in Combination with High-Dose Daunorubicin in 7+3 Induction for Acute Myeloid Leukemia with FLT3 Mutation61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Increased Frequency of IDH1/2 Mutations in Extramedullary Acute Myeloid Leukemia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
Leukemia, Infertility Survivor Shares Story of Faith & HopeMarch 8th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
